Sandu Pharmaceuticals Ltd.

SANDUPHQ

₹48.88

-0.81% (-0.4)

Market Cap

₹47 Cr.

P/E

30.11

Key Ratios

Edit Ratio's

Market cap

47.00 Cr

30.11

Prom Holding

42.90 %

ROE (%)

3.60

ROCE (%)

5.11

Div Yield (%)

1.65

Sales

64.42 Cr

OPM (%)

3.68 %

Debt to Equity

Edit Ratio's

About

Sandu Pharmaceuticals Limited was incorporated in India on November 15, 1985. The company is m… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Sandu Pharmaceuticals Ltd. Business

What does Sandu Pharmaceutical do?

Sandu Pharmaceuticals Limited, incorporated in India in 1985, manufactures and trades Ayurvedic medicines under the brand name SANDU with a manufacturing plant in Goa.

Who are the competitors of Sandu Pharmaceutical?

Sandu Pharmaceutical major competitors are Bandaram Pharma Pack, Deccan Health Care, Kabra Drugs, JFL Life Sciences, Shelter Pharma, Veerhealth Care, Lasa Supergenerics.
Market Cap of Sandu Pharmaceutical is ₹48 Crs.
While the median market cap of its peers are ₹48 Crs.

Is Sandu Pharmaceutical financially stable compared to its competitors?

Sandu Pharmaceutical seems to be less financially stable compared to its competitors.
Altman Z score of Sandu Pharmaceutical is 4.88 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Sandu Pharmaceuticals Ltd.

View the discussion on ValuePickr

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Sandu Pharmaceuticals Ltd.

Sandu Pharmaceuticals Ltd.

Key Ratios

About

Timeline

Company Timeline

9 Yes

1 Neutral

7 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Revenue Recognition

Promoter Holding

Retail Holding

Price & Performance

ROE

Working Capital

Debt

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Share price

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

What does Sandu Pharmaceutical do?

Who are the competitors of Sandu Pharmaceutical?

Is Sandu Pharmaceutical financially stable compared to its competitors?

SIGN UP FOR FREE